2016
DOI: 10.1016/j.mcn.2016.03.008
|View full text |Cite
|
Sign up to set email alerts
|

The long non-coding RNA FMR4 promotes proliferation of human neural precursor cells and epigenetic regulation of gene expression in trans

Abstract: Triplet repeat expansions in the Fragile X mental retardation 1 (FMR1) gene cause either intellectual disability and autism, or adult-onset neurodegeneration, with poorly understood variability in presentation. Previous studies have identified several long noncoding RNAs (lncRNAs) at the FMR1 locus, including FMR4. Similarly to FMR1, FMR4 is silenced by large-repeat expansions that result in enrichment of DNA and histone methylation within the shared promoter and repeat sequence, suggesting a possible role for… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
36
0
1

Year Published

2016
2016
2023
2023

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 42 publications
(37 citation statements)
references
References 44 publications
0
36
0
1
Order By: Relevance
“…They also expand upon limited recent research illustrating a role for Fmr1 following EtOH exposure, albeit one that was, until now, exclusive to the hippocampus (Mulholland et al., ; Spencer et al., ; Wolfe et al., ). Fmr1 is a dynamic epigenetic target that can alter expression of hundreds of transcripts, but that itself may also be regulated by microRNAs (Kenny et al., ; Liu et al., ; Tan et al., ) or its own noncoding antisense RNA Fxr4 (Pastori et al., ; Peschansky et al., ). Given that acute and chronic EtOH alter microRNA and long noncoding RNA networks (Miranda et al., ; Osterndorff‐Kahanek et al., ; Teppen et al., ), future experiments should examine other epigenetic regulations of Fmr1 beyond the histone acetylation examined here in order to further elucidate the role of Fmr1 and its regulatory gene network in the neural response to EtOH, particularly the ataxic effects of EtOH.…”
Section: Discussionmentioning
confidence: 99%
“…They also expand upon limited recent research illustrating a role for Fmr1 following EtOH exposure, albeit one that was, until now, exclusive to the hippocampus (Mulholland et al., ; Spencer et al., ; Wolfe et al., ). Fmr1 is a dynamic epigenetic target that can alter expression of hundreds of transcripts, but that itself may also be regulated by microRNAs (Kenny et al., ; Liu et al., ; Tan et al., ) or its own noncoding antisense RNA Fxr4 (Pastori et al., ; Peschansky et al., ). Given that acute and chronic EtOH alter microRNA and long noncoding RNA networks (Miranda et al., ; Osterndorff‐Kahanek et al., ; Teppen et al., ), future experiments should examine other epigenetic regulations of Fmr1 beyond the histone acetylation examined here in order to further elucidate the role of Fmr1 and its regulatory gene network in the neural response to EtOH, particularly the ataxic effects of EtOH.…”
Section: Discussionmentioning
confidence: 99%
“…LncRNAs have regulatory roles in gene expression at both the transcriptional and post-transcriptional levels in diverse cellular contexts and biological processes. lncRNAs are responsible for nuclear structure integrity, and can regulate the expression of either nearby genes (acting in cis in the nucleus) or genes elsewhere in cells (acting in trans in the nucleus or cytoplasm) by interacting with proteins, RNAs, and DNAs [ 55 , 56 ]. Cis acting lncRNAs are those acting on neighboring target genes [ 55 ].…”
Section: Methodsmentioning
confidence: 99%
“…Among these genes, there was an enrichment for those involved in neural development and cellular proliferation. Indeed, it was further demonstrated that FMR1-AS1 may promote cellular proliferation of hNPCs [91]. It was also proposed that altered FMR1-AS1 expression might contribute to some clinical aspects of FXS/FXTAS [89].…”
Section: Huntington's Diseasementioning
confidence: 99%